Impact of T-cell chimerism on relapse after cord blood transplantation for hematological malignancies: Nagoya Blood and Marrow Transplantation Group study

[1]  E. Shpall,et al.  Mixed T Lymphocyte Chimerism after Allogeneic Hematopoietic Transplantation Is Predictive for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[2]  A. Petrovič,et al.  Chimerism-based pre-emptive immunotherapy with fast withdrawal of immunosuppression and donor lymphocyte infusions after allogeneic stem cell transplantation for pediatric hematologic malignancies. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[3]  T. Naoe,et al.  Chimerism status after unrelated donor bone marrow transplantation with fludarabine-melphalan conditioning is affected by the melphalan dose and is predictive of relapse , 2015, Annals of Hematology.

[4]  P. Chevallier,et al.  Complete donor T cell chimerism predicts lower relapse incidence after standard double umbilical cord blood reduced-intensity conditioning regimen allogeneic transplantation in adults. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[5]  P. Chevallier,et al.  Complete Donor T-Cell Chimerism Predicts Lower Relapse Incidence after Standard Double Umbilical Cord Blood Reduced Intensity Conditioning Regimen Allogeneic Transplantation in Adults , 2014 .

[6]  B. Dörken,et al.  Comparison of chimerism and minimal residual disease monitoring for relapse prediction after allogeneic stem cell transplantation for adult acute lymphoblastic leukemia. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[7]  L. Xu,et al.  Quantitative chimerism: an independent acute leukemia prognosis indicator following allogeneic hematopoietic SCT , 2014, Bone Marrow Transplantation.

[8]  C. Oudin,et al.  Peripheral blood cells chimerism after unrelated cord blood transplantation in children: kinetics, predictive factors and impact on post‐transplant outcome , 2014, British journal of haematology.

[9]  Chun Wang,et al.  Chimerism status is correlated to acute graft-versus-host disease after allogeneic stem cell transplantation , 2014, International Journal of Hematology.

[10]  D. Blaise,et al.  Acute GVHD is a strong predictor of full donor CD3+ T cell chimerism after reduced intensity conditioning allogeneic stem cell transplantation , 2012, American journal of hematology.

[11]  P. Ljungman,et al.  Factors With an Impact on Chimerism Development and Long-Term Survival After Umbilical Cord Blood Transplantation , 2012, Transplantation.

[12]  F. Frommlet,et al.  The EuroChimerism concept for a standardized approach to chimerism analysis after allogeneic stem cell transplantation , 2012, Leukemia.

[13]  A. Petrovič,et al.  Feasibility study of preemptive withdrawal of immunosuppression based on chimerism testing in children undergoing myeloablative allogeneic transplantation for hematologic malignancies , 2009, Bone Marrow Transplantation.

[14]  H. Saito,et al.  Leukemic relapse in the central nervous system after allogeneic stem cell transplantation with complete remission in the bone marrow and donor‐type chimerism: Report of two cases , 2005, American journal of hematology.

[15]  A. Piekarska,et al.  Early complete donor hematopoietic chimerism in peripheral blood indicates the risk of extensive graft-versus-host disease , 2005, Bone Marrow Transplantation.